JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on December 14, 2007; DOI: 10.1124/jpet.107.132647


0022-3565/08/3243-948-956$20.00
JPET 324:948-956, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
jpet.107.132647v1
324/3/948    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lindemann, L.
Right arrow Articles by Hoener, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lindemann, L.
Right arrow Articles by Hoener, M. C.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*AMPHETAMINE
*DOPAMINE

NEUROPHARMACOLOGY

Trace Amine-Associated Receptor 1 Modulates Dopaminergic ActivityFormula

Lothar Lindemann, Claas Aiko Meyer, Karine Jeanneau, Amyaouch Bradaia, Laurence Ozmen, Horst Bluethmann, Bernhard Bettler, Joseph G. Wettstein, Edilio Borroni, Jean-Luc Moreau, and Marius C. Hoener

Pharmaceuticals Division, Central Nervous System Research (L.L., K.J., L.O., J.G.W., E.B., J.-L.M., M.C.H.) and Roche Center for Medical Genomics (C.A.M., H.B.), F. Hoffmann-La Roche Ltd., Basel, Switzerland; and Department of Biomedicine, Institute of Physiology, Pharmacenter, University of Basel, Basel, Switzerland (A.B., B.B.)

The recent identification of the trace amine-associated receptor (TAAR)1 provides an opportunity to dissociate the effects of trace amines on the dopamine transporter from receptor-mediated effects. To separate both effects on a physiological level, a Taar1 knockout mouse line was generated. Taar1 knockout mice display increased sensitivity to amphetamine as revealed by enhanced amphetamine-triggered increases in locomotor activity and augmented striatal release of dopamine compared with wild-type animals. Under baseline conditions, locomotion and extracellular striatal dopamine levels were similar between Taar1 knockout and wild-type mice. Electrophysiological recordings revealed an elevated spontaneous firing rate of dopaminergic neurons in the ventral tegmental area of Taar1 knock-out mice. The endogenous TAAR1 agonist p-tyramine specifically decreased the spike frequency of these neurons in wild-type but not in Taar1 knockout mice, consistent with the prominent expression of Taar1 in the ventral tegmental area. Taken together, the data reveal TAAR1 as regulator of dopaminergic neurotransmission.


Received October 9, 2007; accepted December 13, 2007.

Address correspondence to: Dr. Marius C. Hoener, Pharmaceuticals Division, Central Nervous System Research, Department PRDNP5 CH, Bldg. 70/331, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland. E-mail: marius.hoener{at}roche.com




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
Z. Xie and G. M. Miller
A Receptor Mechanism for Methamphetamine Action in Dopamine Transporter Regulation in Brain
J. Pharmacol. Exp. Ther., July 1, 2009; 330(1): 316 - 325.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
J. J. Maguire, W. A. E. Parker, S. M. Foord, T. I. Bonner, R. R. Neubig, and A. P. Davenport
International Union of Pharmacology. LXXII. Recommendations for Trace Amine Receptor Nomenclature
Pharmacol. Rev., March 1, 2009; 61(1): 1 - 8.
[Abstract] [Full Text] [PDF]


Home page
Learn. Mem.Home page
T. W. Bredy and M. Barad
Social modulation of associative fear learning by pheromone communication
Learn. Mem., December 30, 2008; 16(1): 12 - 18.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Z. Xie and G. M. Miller
{beta}-Phenylethylamine Alters Monoamine Transporter Function via Trace Amine-Associated Receptor 1: Implication for Modulatory Roles of Trace Amines in Brain
J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 617 - 628.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Z. Xie, S. V. Westmoreland, and G. M. Miller
Modulation of Monoamine Transporters by Common Biogenic Amines via Trace Amine-Associated Receptor 1 and Monoamine Autoreceptors in Human Embryonic Kidney 293 Cells and Brain Synaptosomes
J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 629 - 640.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.